LCM
STJ

Laurion Capital Management’s St Jude Medical STJ Stock Holding History

Laurion Capital Management’s Portfolio STJ Stock Details STJ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-5,450
Closed -$437K – 1731
2016
Q4 		$437K Buy
+5,450
New +$433K ﹤0.01% 867
2015
Q4 		– Sell
-6,500
Closed -$410K – 1185
2015
Q3 		$410K Buy
+6,500
New +$464K ﹤0.01% 464
2015
Q1 		– Sell
-28,000
Closed -$1.82M – 515
2014
Q4 		$1.82M Buy
+28,000
New +$1.8M 0.04% 139

Other funds holding STJ

FPF
FNY Partners Fund New York $185M AUM 32.57% 1-Year Est. Return
JWA
JFS Wealth Advisors Hermitage, Pennsylvania $2.01B AUM 21.74% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $374B AUM 17.66% 1-Year Est. Return
AIM
Advantage Investment Management Cedar Rapids, Iowa $128M AUM 0.94% 1-Year Est. Return

Laurion Capital Management's STJ Position: Q1 2017 in Review

Laurion Capital Management sold out of St Jude Medical (STJ) in Q1 2017, closing a stake of 5,450 shares — an estimated $437K sold.

Laurion Capital Management first reported a position in STJ in Q4 2014 and held it in 3 quarters. The position peaked at $1.82M in Q4 2014. 4 funds tracked by Wall St. Rank hold STJ as of Q1 2017.

  • Laurion Capital Management reported no remaining St Jude Medical position as of Q1 2017 after selling out during the quarter.
  • Laurion Capital Management sold 5,450 St Jude Medical shares in Q1 2017, an estimated $437K.
  • Laurion Capital Management first reported a position in St Jude Medical in Q4 2014 and held it in 3 quarters.
  • Laurion Capital Management's St Jude Medical position peaked at $1.82M in Q4 2014.
  • 4 funds tracked by Wall St. Rank held St Jude Medical as of Q1 2017.

Based on Laurion Capital Management's 13F filing for Q1 2017, filed 12 May 2017.